Affinage

KCTD8

BTB/POZ domain-containing protein KCTD8 · UniProt Q6ZWB6

Length
473 aa
Mass
52.4 kDa
Annotated
2026-04-28
14 papers in source corpus 8 papers cited in narrative 8 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

KCTD8 is an auxiliary subunit of GABAB receptors that shapes receptor signaling kinetics, subcellular trafficking, and downstream effector coupling in neurons. Its T1 domain binds GABAB2 to mediate receptor association, while a unique H2 domain sterically blocks H1-mediated desensitization, generating non-desensitizing GABAB receptor responses; KCTD8 also slightly increases GABA affinity and reduces tonic G-protein activation (PMID:23035119, PMID:25196734). Beyond GABAB receptors, KCTD8 directly binds and potentiates Cav2.3 (R-type) calcium channels independently of GABAB signaling and facilitates axonal trafficking of GABAB receptors in habenula cholinergic neurons to enable presynaptic excitatory modulation (PMID:33913808, PMID:35017224). KCTD8 hetero-oligomerizes with KCTD12, KCTD16, and KCTD5 through T1 and H1 domains, expanding the functional diversity of native receptor complexes, and additionally suppresses PI3K/AKT signaling to inhibit hepatocellular carcinoma growth (PMID:28003345, PMID:39023358).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 2011 Medium

    Establishing KCTD8 as a GABAB receptor auxiliary subunit resolved how subunit-specific properties such as non-desensitizing responses and distinct subcellular localization arise in native receptor complexes.

    Evidence In situ hybridization, immunohistochemistry, and biochemical co-assembly in brain tissue and heterologous cells

    PMID:21452234

    Open questions at the time
    • Molecular domains mediating receptor binding and desensitization control were undefined
    • Pharmacological consequences of KCTD8 association were not quantified
    • Single-lab study without independent replication at this stage
  2. 2012 High

    Mapping the domain architecture of KCTD8 revealed that the T1 domain mediates GABAB2 binding and an H2 domain unique to KCTD8/16 sterically prevents H1-mediated desensitization, explaining how KCTD8 generates non-desensitizing responses.

    Evidence Domain deletion/chimera mutagenesis combined with electrophysiological recordings in transfected cells

    PMID:23035119

    Open questions at the time
    • Structural basis for H2-mediated steric inhibition was not resolved
    • Whether the same mechanism operates at native synapses was untested
  3. 2014 High

    Quantifying KCTD8's pharmacological effects showed it increases GABA affinity and reduces tonic G-protein activation, explaining enhanced positive allosteric modulator efficacy at KCTD8-containing receptors.

    Evidence [35S]GTPγS binding, BRET between G-protein subunits, and Kir3 current recordings in CHO cells and hippocampal neurons

    PMID:25196734

    Open questions at the time
    • Mechanism by which KCTD8 reduces tonic G-protein activation was not identified
    • In vivo pharmacological relevance was not tested
  4. 2016 High

    Demonstrating that KCTD8 hetero-oligomerizes with KCTD12 and KCTD16 through T1 and H1 domains established that combinatorial KCTD assembly diversifies native GABAB receptor properties.

    Evidence Reciprocal co-immunoprecipitation, live-cell BRET, and electrophysiology in KCTD knock-out mouse hippocampal neurons

    PMID:28003345

    Open questions at the time
    • Stoichiometry of hetero-oligomeric complexes was not determined
    • Functional consequences of specific hetero-oligomer combinations in defined circuits were unknown
  5. 2021 High

    Discovering that KCTD8 directly binds and potentiates Cav2.3 channels independently of GABAB receptors revealed a receptor-independent ion channel regulatory function at presynaptic terminals.

    Evidence Heterologous cell Cav2.3 current recordings, immunofluorescence co-localization in rostral IPN, and KCTD8 genetic deletion mouse models with transmitter release assays

    PMID:33913808

    Open questions at the time
    • Binding interface between KCTD8 and Cav2.3 was not mapped
    • Whether KCTD8 modulates other Cav channel subtypes was untested
  6. 2022 High

    Showing that KCTD8 facilitates axonal trafficking of GABAB receptors in habenula cholinergic neurons explained how KCTD isoforms control the subcellular compartmentalization of receptor signaling and enable presynaptic excitation.

    Evidence Combinatorial KCTD isoform knock-out mice, electrophysiology of glutamate release and presynaptic Ca2+, viral KCTD8 overexpression rescue in triple-KO animals

    PMID:35017224

    Open questions at the time
    • Molecular mechanism of axonal trafficking promotion (motor adaptors, sorting signals) was not identified
    • Whether this trafficking role extends beyond habenula cholinergic neurons was unknown
  7. 2023 Medium

    Identification of KCTD8–KCTD5 hetero-oligomers broadened the interactome beyond the GABAB-associated KCTD clade, suggesting cross-family combinatorial assembly.

    Evidence Co-immunoprecipitation, live-cell BRET, and IP-luminescence domain mapping

    PMID:37762619

    Open questions at the time
    • Functional consequence of KCTD8–KCTD5 interaction was not determined
    • Study focused primarily on KCTD5; reciprocal validation from KCTD8 perspective was limited
    • In vivo relevance of this interaction was not tested
  8. 2024 Medium

    Demonstrating that KCTD8 suppresses hepatocellular carcinoma growth via PI3K/AKT pathway inhibition revealed a non-neuronal tumor-suppressive role regulated by promoter methylation.

    Evidence Flow cytometry, immunoprecipitation, xenograft mouse models, and methylation-specific PCR in HCC cell lines

    PMID:39023358

    Open questions at the time
    • Direct molecular target within PI3K/AKT pathway was not identified
    • Whether BTB-domain ubiquitin ligase activity underlies AKT suppression was not tested
    • Single study without independent replication

Open questions

Synthesis pass · forward-looking unresolved questions
  • The structural basis of KCTD8's H2 domain steric block, the molecular mechanism by which it promotes axonal receptor trafficking, the binding interface with Cav2.3, and the direct target in PI3K/AKT signaling remain unresolved.
  • No high-resolution structure of KCTD8 or its complexes exists
  • Axonal trafficking mechanism (motor adaptors, sorting signals) is unknown
  • Direct molecular link between KCTD8 and PI3K/AKT pathway is uncharacterized

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098772 molecular function regulator activity 3
Localization
GO:0005886 plasma membrane 3
Pathway
R-HSA-162582 Signal Transduction 4 R-HSA-112316 Neuronal System 2
Complex memberships
GABAB receptor complex

Evidence

Reading pass · 8 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2011 KCTD8 was identified as an auxiliary subunit of GABAB receptors that associates with the receptor complex, influences biophysical and pharmacological properties of the receptor response, and generates largely non-desensitizing receptor responses. Distinct axonal or dendritic subcellular localizations were observed for individual KCTD proteins in neuronal populations. In situ hybridization, immunohistochemistry, biochemical co-assembly data The Journal of comparative neurology Medium 21452234
2012 KCTD8 generates non-desensitizing GABAB receptor responses. The T1 domain of KCTD8 binds to GABAB2. KCTD8 contains an H2 homology domain (absent in KCTD12/12b) that sterically inhibits desensitization in a sequence-independent manner. The H1 domain of KCTD8 lacks the T/NFLEQ motif responsible for desensitization in KCTD12/12b. Domain deletion/chimera mutagenesis, electrophysiological recordings in transfected cells, evolutionary sequence analysis The Journal of biological chemistry High 23035119
2014 KCTD8 slightly but significantly increases GABA affinity at recombinant GABAB receptors. KCTD8 also reduces tonic G-protein activation when co-expressed with GABAB receptors, leading to a larger increase in efficacy by the positive allosteric modulator GS39783 compared to receptors lacking KCTDs. [35S]GTPγS binding assay, BRET between G-protein subunits, Kir3 current recordings in transfected CHO cells and hippocampal neurons Neuropharmacology High 25196734
2016 KCTD8 hetero-oligomerizes with other KCTD subunits (KCTD12, KCTD16) through self-interacting T1 and H1 homology domains. KCTD8-containing hetero-oligomers associate with both the GABAB receptor and the G-protein, expanding the functional repertoire of native GABAB receptors. Coimmunoprecipitation, BRET in live cells, electrophysiology in heterologous cells and KCTD knock-out mouse hippocampal neurons The Journal of neuroscience High 28003345
2021 KCTD8 directly binds to R-type Ca2+ channels (Cav2.3) in heterologous cells and potentiates Cav2.3 currents independently of GABAB receptor activation. In the rostral IPN, KCTD8 co-localizes with KCTD12b and Cav2.3 at the presynaptic active zone, and genetic deletion of KCTD8 modulates Cav2.3-mediated transmitter release, revealing a GABAB receptor-independent function. Heterologous cell expression with electrophysiology (Cav2.3 current recordings), co-localization by immunofluorescence, genetic deletion mouse models eLife High 33913808
2022 KCTD8 (together with KCTD12) facilitates axonal expression of GABAB receptors in habenula cholinergic neurons and thereby promotes presynaptic excitation (potentiation of glutamate release and Ca2+ entry) by GABAB receptors. Overexpressing KCTD8 in KCTD8/12/16 triple knock-out mice rescued axonal GABAB expression and presynaptic excitation, demonstrating an isoform-specific role. Multiple KCTD isoform-specific knock-out mouse lines, electrophysiology (glutamate release, presynaptic Ca2+ measurements), immunofluorescence of axonal vs. somatic GABAB expression, viral overexpression rescue experiments The Journal of neuroscience High 35017224
2023 KCTD8 forms hetero-oligomeric complexes with KCTD5 (and other KCTD family members), with different regions on KCTD5 contributing to interactions with distinct KCTD partners including KCTD8. Co-immunoprecipitation in lysed cells, live-cell BRET, IP-luminescence domain mapping International journal of molecular sciences Medium 37762619
2024 KCTD8 suppresses hepatocellular carcinoma cell growth in vitro and in vivo by inhibiting the PI3K/AKT signaling pathway. KCTD8 expression is regulated by promoter DNA methylation in HCC. Flow cytometry, immunoprecipitation, xenograft mouse models, methylation-specific PCR Epigenomics Medium 39023358

Source papers

Stage 0 corpus · 14 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2012 Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 77 22930747
2011 Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain. The Journal of comparative neurology 73 21452234
2016 KCTD Hetero-oligomers Confer Unique Kinetic Properties on Hippocampal GABAB Receptor-Induced K+ Currents. The Journal of neuroscience : the official journal of the Society for Neuroscience 48 28003345
2012 Opposite effects of KCTD subunit domains on GABA(B) receptor-mediated desensitization. The Journal of biological chemistry 47 23035119
2015 Altered emotionality and neuronal excitability in mice lacking KCTD12, an auxiliary subunit of GABAB receptors associated with mood disorders. Translational psychiatry 43 25689571
2013 Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12). The Journal of biological chemistry 36 23843457
2014 Pharmacological characterization of GABAB receptor subtypes assembled with auxiliary KCTD subunits. Neuropharmacology 31 25196734
2011 KCTD8 gene and brain growth in adverse intrauterine environment: a genome-wide association study. Cerebral cortex (New York, N.Y. : 1991) 30 22156575
2013 A genome-wide search for type 2 diabetes susceptibility genes in an extended Arab family. Annals of human genetics 27 23937595
2021 GABAB receptor auxiliary subunits modulate Cav2.3-mediated release from medial habenula terminals. eLife 21 33913808
2022 KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience 12 35017224
2023 KCTD5 Forms Hetero-Oligomeric Complexes with Various Members of the KCTD Protein Family. International journal of molecular sciences 11 37762619
2023 Uncovering structural variants associated with body weight and obesity risk in labrador retrievers: a genome-wide study. Frontiers in genetics 4 37799139
2024 Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling. Epigenomics 1 39023358